What are the three items included in the cerebral infarction panel?
Nov 12, 2024
Source: Cainiu Health
Dr. Lv Zhiqin
Introduction
The myocardial enzyme spectrum mainly includes creatine kinase, aspartate transaminase, and lactate dehydrogenase. In patients with cerebral infarction, elevations in the myocardial enzyme spectrum tend to occur early, and the degree of elevation becomes more pronounced when the condition is severe. These tests enable physicians to fully understand the patient's condition and provide a basis for developing appropriate treatment plans.
Generally speaking, cerebral infarction refers to cerebral infarct. The usual tests for cerebral infarction include blood pressure, blood glucose, blood lipids, blood homocysteine, and myocardial enzymes. Details are as follows:
1. Blood pressure: Patients with cerebral infarction usually require blood pressure monitoring to ensure it is maintained within a certain range, thus reducing the risk of recurrence. Normal blood pressure should be controlled below 140/90 mmHg. For patients with hypertension, special attention should be given to blood pressure control, ideally maintaining it around 120/80 mmHg. For elderly patients, the blood pressure control standard can be appropriately relaxed, generally maintained around 130/80 mmHg.
2. Blood glucose: Blood glucose level is another important indicator that needs monitoring in patients with cerebral infarction. Normally, fasting blood glucose should be between 3.9 and 6.1 mmol/L. For patients with cerebral infarction, fasting blood glucose should be controlled below 8.0 mmol/L, and postprandial 2-hour blood glucose should be controlled below 8.5 mmol/L. If the patient has diabetes, fasting blood glucose should be controlled below 7.0 mmol/L, and postprandial 2-hour blood glucose should be controlled below 10.0 mmol/L. Hyperglycemia may exacerbate cerebral ischemic injury, so controlling blood glucose is very important for patients with cerebral infarction.
3. Blood lipids: Blood lipid levels also significantly impact the health of patients with cerebral infarction. Blood lipids mainly include total cholesterol, triglycerides, and high-density lipoprotein cholesterol. Normally, the reference range for total cholesterol is 2.8-5.20 mmol/L, and for triglycerides, it is 0.5-61.70 mmol/L. Hyperlipidemia may lead to atherosclerosis, increasing the risk of cerebral infarction. Therefore, patients with cerebral infarction should regularly monitor their blood lipid levels, and if necessary, receive lipid-lowering therapy with statins.
4. Blood homocysteine: Homocysteine is an intermediate product of methionine and cysteine metabolism. Normally, its level ranges between 5-15 μmol/L. Vascular lesions in patients with cerebral infarction may cause elevated blood homocysteine levels. Therefore, monitoring blood homocysteine levels plays an important role in assessing the risk of cerebral infarction. Elevated blood homocysteine may indicate a risk of cerebral arteriosclerosis in the patient.
5. Myocardial enzymes: The myocardial enzyme panel mainly includes creatine kinase, aspartate aminotransferase, lactate dehydrogenase, etc. In patients with cerebral infarction, elevation of myocardial enzymes occurs early, and the degree of elevation becomes more pronounced with the severity of the condition. Therefore, monitoring myocardial enzyme levels helps assess myocardial damage in patients with cerebral infarction.
These tests help doctors comprehensively understand the patient's condition and provide a basis for formulating appropriate treatment plans.
